Mutational analysis of 35 bladder cancer cell lines using RNA-seq.

10
Mutational analysis of 35 bladder cancer cell lines using RNA-seq

Transcript of Mutational analysis of 35 bladder cancer cell lines using RNA-seq.

Page 1: Mutational analysis of 35 bladder cancer cell lines using RNA-seq.

Mutational analysis of 35 bladder cancer cell lines using RNA-seq

Page 2: Mutational analysis of 35 bladder cancer cell lines using RNA-seq.

RNA-seqCell lines

Genes

Page 3: Mutational analysis of 35 bladder cancer cell lines using RNA-seq.

Frequently mutated networks in bladder cancer cell lines

Page 4: Mutational analysis of 35 bladder cancer cell lines using RNA-seq.

Mutations in CBP/p300 network

Nonsense Missense Fusion

Page 5: Mutational analysis of 35 bladder cancer cell lines using RNA-seq.

Mutations in chromatin remodelling genes

Nonsense Missense Fusion

Page 6: Mutational analysis of 35 bladder cancer cell lines using RNA-seq.

Mutations in oncogenic networks

Nonsense Missense Fusion

Page 7: Mutational analysis of 35 bladder cancer cell lines using RNA-seq.

FGFR3 chr4 1808660 BAIAP2L1 chr7 97991743 73 158 90

Page 8: Mutational analysis of 35 bladder cancer cell lines using RNA-seq.

Mutations in tumor suppressors

Nonsense Missense Fusion

Page 9: Mutational analysis of 35 bladder cancer cell lines using RNA-seq.

Expression of ER stress response genes in bladder cancer cell lines

Page 10: Mutational analysis of 35 bladder cancer cell lines using RNA-seq.

XBP1 splicing in bladder cancer cell lines

26nt